Skip to Content

What type of cancer is Tecentriq used to treat?

Medically reviewed by Last updated on Dec 5, 2019.

Official Answer


Tecentriq (atezolizumab) is used to treat:

Tecentriq was the first programmed death-ligand 1 (PD-L1) blocking antibody approved by the FDA.

Tecentriq belongs to a class of immunotherapy drugs called immune checkpoint inhibitors and works by boosting the body’s immune system to help it attack cancer cells. Immune checkpoint inhibitors may also allow the immune system to attack normal organs in the body which may lead to serious side effects, but overall these drugs are better tolerated than many of the older standard cancer treatments.

Common side effects with Tecentriq may include fatigue, loss of appetite, and nausea. Other more serious side effects may include hepatitis, inflammation in the lungs, intestines, or other organs.

Related Medical Questions

Drug Information

Related Support Groups